Buttercup Bronchostop Cough pastilles

Land: Storbritannien

Språk: engelska

Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiva substanser:

Thyme

Tillgänglig från:

Omega Pharma Ltd

INN (International namn):

Thyme

Dos:

59.5mg

Läkemedelsform:

Pastille

Administreringssätt:

Oromucosal

Klass:

No Controlled Drug Status

Receptbelagda typ:

Valid as a prescribable product

Produktsammanfattning:

BNF: 12030300; GTIN: 5012616262227 5012616262234 5012616262241

Bipacksedel

PACKAGE LEAFLET: INFORMATION FOR THE USER
Buttercup Bronchostop Cough Pastilles
Thyme herb extract
Read all of this leaflet carefully before you start taking this
medicine because it contains
important information for you.
Always use this medicine exactly as described in this leaflet or as
your doctor, pharmacist or
qualified healthcare practitioner has told you.
- Keep this leaflet. You may need to read it again.
-
Ask your pharmacist or qualified healthcare practitioner if you need
more information or advice.
- If you get any side effects, talk to your pharmacist. This includes
any possible side effects not
listed in this leaflet. See section 4.
- You must talk to a doctor or qualified healthcare practitioner if
you do not feel better or if you
feel worse after 7 days.
What is in this leaflet:
1. What Buttercup Bronchostop Cough Pastilles are and what they are
used for
2. What you need to know before you take Buttercup Bronchostop Cough
Pastilles
3. How to take Buttercup Bronchostop Cough Pastilles
4. Possible side effects
5. How to store Buttercup Bronchostop Cough Pastilles
6. Contents of the pack and other information
1. WHAT BUTTERCUP BRONCHOSTOP COUGH
PASTILLES ARE AND WHAT THEY ARE USED FOR
Buttercup Bronchostop Cough Pastilles are a
traditional herbal medicinal product used for the relief
of coughs, such as chesty coughs and dry, tickly,
irritating coughs and catarrh based on traditional use
only.
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE BUTTERCUP BRONCHOSTOP COUGH
PASTILLES
Do not take Buttercup Bronchostop Cough
Pastilles
• If you are allergic to Thyme or other members
of the Lamiaceae family (e.g. Basil, Rosemary,
Sage), or to any of the other ingredients of this
medicine (listed in section 6).
• If you are pregnant or breast-feeding.
Warnings and precautions
Consult your doctor before taking Buttercup
Bronchostop Cough Pastilles if you:
• are prone to develop allergic reactions. There is a
possible risk that this medicine may trigger severe
and life-threatening allergic reactions in patients
wh

Produktens egenskaper

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Buttercup Bronchostop Cough Pastilles
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each pastille contains 59.5 mg of extract (as dry extract) from Thyme
herb
(Thymus vulgaris L. and Thymus zygis L., herb ) (DER 7-13:1)
extraction
solvent: water
Excipient(s) with known effect:
Each pastille contains: 523 mg sorbitol (E420), 300 mg fructose, 5.53
mg
propylene-glycol (E1520) and 0.0018 mg benzyl-alcohol (E1519)
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Hexagonal, brown pastilles with a fruity taste.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Traditional herbal medicinal product used for the relief of coughs,
such as
chesty
coughs
and
dry,
tickly,
irritating
coughs
and
catarrh,
based
on
traditional use only.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
_ _
Adults, the elderly and children over 12 years:
1 – 2 pastilles to be taken every 4 hours, 4 times a day. If
required, up to a
maximum of 12 pastilles can be taken per day.
_ _
_Method of administration:_
For oral use (allow to dissolve in the mouth through sucking).
This product is not recommended for use in children under 12 years of
age
(See ‘Section 4.4 Special warnings and precautions for use.’)
_Duration of use: _
_ _
If symptoms worsen, or persist after 7 days, a doctor or a qualified
healthcare
practitioner should be consulted.
4.3
CONTRAINDICATIONS
Hypersensitivity to Thyme or to other members of the Lamiaceae family,
or to any of
the excipients listed in section 6.1.
4.4
SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Do not exceed the stated dose.
The use in children under 12 years of age is not recommended due to
lack of data and
because medical advice should be sought.
If symptoms worsen, or persist after 7 days, a doctor or qualified
healthcare
practitioner should be consulted.
If dyspnoea, fever or purulent sputum occurs, a doctor or qualified
healthcare
practitioner should be consulted.
Patients with asthma should consult their doctor before using
Butt